SciELO - Scientific Electronic Library Online

 
vol.26 suppl.1Efecto del conocimiento y nivel socioeconómico sobre las actividades de control realizadas por la población en riesgo de adquirir leishmaniasis cutánea en la región subandina del departamento del Huila, ColombiaEficacia y tolerancia de la pentamidina en el tratamiento de la leishmaniasis cutánea producida por Leishmania (V.) panamensis en Colombia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Biomédica

versión impresa ISSN 0120-4157versión On-line ISSN 2590-7379

Resumen

BRITO, Solanny et al. Efficacy of a kaurenic acid extracted from the Venezuelan plant Wedelia trilobata (Asteracea) against Leishmania (Viannia) braziliensis. Biomédica [online]. 2006, vol.26, suppl.1, pp.180-187. ISSN 0120-4157.

Introduction. Leishmaniasis is a global public health problem without adequate treatment options, hence requiring research on new drug development. Objective. Our main objective was the evaluation of a kaurenic acid (ent-kaur-16-in-19-oico), isolated from the Venezuelan plant Wedelia trilobata (Asteracea), on Leishmania (V) braziliensis both in vivo and in vitro. Materials and methods. The in vitro assay was performed using axenic amastigotes and promastigotes as well as infected and uninfected macrophages. Parasites and macrophages were treated with concentrations of the compound varying between 10 and 250 µg/ml. The effect of the compound on cellular viability was evaluated by counting dead and living cells in a hemocytometer and by the colorimetric method using MTT (Methylthiazoletetrazolium). For the in vivo assay, Balb/c mice were infected subcutaneously with 1x106 promastigotes of L.(V.) braziliensis and afterwards treated with a daily dose of 30 mg/kg in 100 µl of kaurenic acid administered by intraperitoneal injection for one week. Results. The compound had a lethal effect on axenic amastigotes and promastigotes with DL50 of 0.25 and 0.78 µg/ml, respectively, in 24 hours. Low toxicity was observed for J774-G8 macrophages with a DL50 of 25 µg/ml and high viability (70-92%), while a moderate viability was observed for infected macrophages (37-81%), with concentrations of 25 µg/ml or less. Additionally, a 70% reduction was observed in the size of the skin lesions in Balb/c mice with no evident toxic effect. Conclusion. The results indicate that this compound has a potent leishmanicidal effect on L.(V.) braziliensis.

Palabras clave : Leishmania; leishmaniasis [drug therapy].

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons